Ayala Pharmaceuticals Kapitalrendite
Was ist das Kapitalrendite von Ayala Pharmaceuticals?
Kapitalrendite von Ayala Pharmaceuticals Inc. ist -45.76%
Was ist die Definition von Kapitalrendite?
Die Eigenkapitalrendite ist ein Maß für die Rentabilität eines Unternehmens im Verhältnis zum Buchwert des Eigenkapitals. Sie wird berechnet, indem das Nettoergebnis des Geschäftsjahres durch das gesamte Eigenkapital geteilt wird.
The return on equity (ROE) ROE is a measure of how well a company uses investments to generate earnings growth. ROE is used for comparing the performance of companies in the same industry. It indicated the management's ability to generate income from the equity available to it. ROEs of 15-20% are generally considered good. ROEs are also a factor in stock valuation, in association with other financial ratios. In general, stock prices are influenced by earnings per share (EPS), so that stock of a company with a 20% ROE will generally cost twice as much as one with a 10% ROE.
Kapitalrendite von Unternehmen in Health Care Sektor auf NASDAQ im Vergleich zu Ayala Pharmaceuticals
Was macht Ayala Pharmaceuticals?
advaxis (nasdaq: adxs) is a late -stage biotechnology company developing multiple cancer immunotherapies based on its proprietary platform that redirects the immune system to kill cancer. the advaxis technology, using bioengineered live attenuated bacteria, listeria monocytogenes (lm), actively suppresses key components in the tumor microenvironment that contribute to the tumors growth and protection from immunologic attack.
Unternehmen mit kapitalrendite ähnlich Ayala Pharmaceuticals
- Tobii AB (publ) hat Kapitalrendite von -45.85%
- Golden Arrow Resources hat Kapitalrendite von -45.81%
- Golden Arrow Resources hat Kapitalrendite von -45.81%
- Trillium Acquisition hat Kapitalrendite von -45.80%
- Artelo Biosciences hat Kapitalrendite von -45.80%
- Capital Finance hat Kapitalrendite von -45.79%
- Ayala Pharmaceuticals hat Kapitalrendite von -45.76%
- NovoCure Ltd hat Kapitalrendite von -45.68%
- Invinity Systems hat Kapitalrendite von -45.67%
- Unisync hat Kapitalrendite von -45.65%
- Patriot Battery Metals Inc hat Kapitalrendite von -45.61%
- Jagatjit Industries hat Kapitalrendite von -45.59%
- Brainhole Technology hat Kapitalrendite von -45.52%